Overview

Acute Montelukast in Asthma

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
Patients presenting to hospital with an acute asthma exacerbation severe enough to require admission would receive full standard treatment according to British Thoracic Society guidelines in addition they would be offered the opportunity to take part in the study which would requite them to take a capsule of either montelukast or placebo.
Phase:
Phase 4
Details
Lead Sponsor:
University of East Anglia
Collaborators:
Merck Sharp & Dohme Corp.
Norfolk Association of Asthma Nurses
Treatments:
Montelukast